Results 121 to 130 of about 27,977,136 (206)

Corrigendum to "Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy" [Pharm. Sci. Adv. 4 (2026) 100109]. [PDF]

Pharm Sci Adv
Zheng R, Wang Z, Zhang B, Li Y, Gao S, Guo Y, Meng D, Mu X, Shao L.   +8 more
europepmc   +1 more source

Correction: Potential surrogate endpoint for B-cell hematologic malignancy: A systematic review and meta-analysis. [PDF]

Sci Rep
Hirano S, Hanada K, Maeda H.
europepmc   +1 more source

Pharmaceutical Sciences

Journal of African Studies, 1971
openaire   +2 more sources

In defence of the drug, two hearts, one profession: Reintegrating medicines expertise and patient-centred care in pharmacy's professional identity. [PDF]

Explor Res Clin Soc Pharm
Davies NM.
europepmc   +1 more source

Erector Spine and Cervical Extensor Muscles in Dysphagia. [PDF]

Geriatr Gerontol Int
Miyagi M, Sekiya H, Ebihara S.
europepmc   +1 more source

Polyamorphism: a pharmaceutical science perspective

Journal of Pharmacy and Pharmacology, 2002
Bruno C, Hancock, Evgenyi Y, Shalaev, Sheri L, Shamblin   +2 more
openaire   +2 more sources

Data-driven subphenotyping uncovers ulcerative colitis subtype with high risk for relapse in Japan: a prospective multicenter cohort study. [PDF]

Lancet Reg Health West Pac
Mikami Y, Yamazaki H, Hisamatsu T, Nagahori M, Kobayashi T, Yonezawa M, Shinzaki S, Fujii T, Saruta M, Motoya S, Yamamoto T, Matsuura M, Omori T, Fukuhara S, Matsuoka K.   +14 more
europepmc   +1 more source

Management of nausea and vomiting with claudin 18.2-targeted therapy in upper gastrointestinal cancer. [PDF]

ESMO Gastrointest Oncol
Wu Z, Shitara K, Lorenzen S.
europepmc   +1 more source

Clinical Pharmacology in China: Seven Decades of Progress in Discipline Development and Education. [PDF]

J Clin Pharmacol
Hao GX, Zhou Y, Tang BH, Zhao HJ, Wei W, van den Anker J, Zhao W.   +6 more
europepmc   +1 more source

Computational applications in secondary metabolite discovery (CAiSMD) 2026: focus on secondary metabolites towards drug discovery. [PDF]

J Cheminform
Ntie-Kang F, Betow JY, Eni DB, Metuge JA, Adriano A, Chama MA, Bamal HD, Kedi PBE, Campos LM, Abdullahi AS, Medina GFF, Mbeket SBN, Adekunle YA, Carvalho ARV, Akamba BDA, Dare CA, Mtulo YB, López-López E, Djoumbou-Feunang Y, Metuge CS, Ndamo S, Shadrack DM, Diallo BN, Bekono BD, Valli M, Mbah JA, Sabiu S, Egieyeh SA, Medina-Franco JL, Ludwig-Müller J.   +29 more
europepmc   +1 more source